Yemarshet Gebreyohannes

Yemarshet Gebreyohannes

University of Minnesota Twin Cities - Minneapolis / United States
Medical and Health Sciences / Pharmacology
AD Scientific Index ID: 4681984
person_outline Yemarshet Gebreyohannes's MOST POPULAR ARTICLES
1-) A precision therapy against cancers driven by KIT/PDGFRA mutations EK Evans, AK Gardino, JL Kim, BL Hodous, A Shutes, A Davis, XJ Zhu, ... Science translational medicine 9 (414), eaao1690, 2017 1382017
2-) Robust activity of avapritinib, potent and highly selective inhibitor of mutated KIT, in patient-derived xenograft models of gastrointestinal stromal tumors YK Gebreyohannes, A Wozniak, ME Zhai, J Wellens, J Cornillie, ... Clinical Cancer Research 25 (2), 609-618, 2019 542019
3-) Anti-tumor activity of the MDM2-TP53 inhibitor BI-907828 in dedifferentiated liposarcoma patient-derived xenograft models harboring MDM2 amplificationJ Cornillie, A Wozniak, H Li, YK Gebreyohannes, J Wellens, D Hompes, ...Clinical and Translational Oncology 22, 546-554, 2020312020
4-) Cabozantinib Is Active against Human Gastrointestinal Stromal Tumor Xenografts Carrying Different KIT MutationsYK Gebreyohannes, P Schöffski, T Van Looy, J Wellens, L Vreys, ...Molecular cancer therapeutics 15 (12), 2845-2852, 2016322016
5-) Establishment and characterization of histologically and molecularly stable soft-tissue sarcoma xenograft models for biological studies and preclinical drug testingJ Cornillie, A Wozniak, H Li, Y Wang, B Boeckx, YK Gebreyohannes, ...Molecular cancer therapeutics 18 (6), 1168-1178, 2019302019